Gossamer Bio (GOSS) Short-term Investments (2022 - 2025)
Historic Short-term Investments for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $171.3 million.
- Gossamer Bio's Short-term Investments fell 4262.95% to $171.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.3 million, marking a year-over-year decrease of 4262.95%. This contributed to the annual value of $248.4 million for FY2024, which is 600.49% down from last year.
- Latest data reveals that Gossamer Bio reported Short-term Investments of $171.3 million as of Q3 2025, which was down 4262.95% from $186.6 million recorded in Q2 2025.
- Gossamer Bio's 5-year Short-term Investments high stood at $298.6 million for Q3 2024, and its period low was $125.1 million during Q2 2023.
- For the 4-year period, Gossamer Bio's Short-term Investments averaged around $195.6 million, with its median value being $186.6 million (2025).
- In the last 5 years, Gossamer Bio's Short-term Investments skyrocketed by 11388.01% in 2024 and then tumbled by 4262.95% in 2025.
- Over the past 4 years, Gossamer Bio's Short-term Investments (Quarter) stood at $143.7 million in 2022, then surged by 83.93% to $264.3 million in 2023, then fell by 6.0% to $248.4 million in 2024, then plummeted by 31.05% to $171.3 million in 2025.
- Its last three reported values are $171.3 million in Q3 2025, $186.6 million for Q2 2025, and $228.9 million during Q1 2025.